ew upsid rais
reiter outperform
up target price expect increas lr off-set potenti risk
bullish outlook base part view ew
yet reflect low-risk expans tavr market investor
appear like look past result toward evid next
quarter increas tavr growth follow lr data new target
multipl ebitda repres premium multipl
compar premium past mo investor gain
confid size long-term tavr market sensit analysi
suggest bil increment long-term expect equat anoth
stock reinforc confid new target
improv lt growth yet discount stock view
despit posit lr-tavr data debat continu size
lr popul draft tavr ncd coverag memo
much support expect also yet reflect estim
stock see tavr ncd expert call final april sentiment
survey show lt tavr expect bare move sinc januari
see signific upsid ew factor reflect stock
 tavr consensu mil estim
though investor may will give pass bottom-up center-
driven revenu build suggest estim doabl
valuat target price base
ev/ebitda multipl bil project ebitda
unch risk product approv delay reimburs chang greater-
than-expect share loss new litig regulatori issu
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
global manufactur provid
medic devic equip structur valvular heart
diseas critic care
price apr rate outperform target price analyst matt miksic
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
 close
one-year valuat scenario base
ev/ebitda ebitda
scenario base emerg segment deliv
growth high-growth segment grow growth
grow
one-year valuat grey scenario base
ev/ebitda grey ebitda grey
scenario base emerg segment deliv
growth high-growth segment grow growth
grow
ew valuat stock perform driven lt tavr market expect
believ signific driver intermediate- long-term perform ew
investor confid size lt tavr market base recent survey
convers investor believ expect increas slightli sinc
risk tavr result present last month howev remain substant
debat wide rang view mani patient new low-risk
indic reach henc continu see wide rang view long-term
market size mind updat analysi potenti impact
stock street consensu increas addit bil bil
bil estim increment bil project tavr market
sale would equat per share upsid stock assum analysi
ew hold ww market share line tavr market model
repres declin ew current share also assum increment
margin discount target multipl discount rate
figur ew sensit chang long-term tavr market expect
project tavr market size
ew market share project
discount ebitda mult target mult
theoret /share impact target
estim
figur ew rel valuat vs
ew premium rel
ew tavr sale wide rang variabl sensit histor
analysi tavr sale includ revenu build base number top
center larg center mid-siz center small center imput
potenti sale number quarter creat rang
like sale figur repres amount revenu upsid downsid creat
center perform one addit one fewer tavr procedur given
quarter right rang variabl quarter repres plu minu
approxim mil base analysi believ estim doabl
compani howev note street slightli estim mil vs
mil tavr clear compani longer provid explicit tavr
sale report ww sale howev expect investor analyst come
approxim sale base manag comment look ahead
base know see estim also doabl
imput revenu line mil often one compani
season stronger quarter case approv
intermediate-risk tavr indic concern street
estim could touch high especi given histor one
compani season weaker quarter said take fundament long-
term view ew would gener view weak quarter ahead
buy opportun bar unforeseen structur chang fundament
figur ew tavr sale rang sensit
charl martineau pm univers toronto compani mention price
